ArticleAnnals of oncology : official journal of the European Society for Medical Oncology2018

Vistusertib (dual m-TORC1/2 inhibitor) in combination with paclitaxel in patients with high-grade serous ovarian and squamous non-small-cell lung cancer.

B Basu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.